Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Bacopa Monnieri vs Sage: Bacopa Monnieri has the stronger overall evidence (6 vs 6/10); they're alternatives for improve memory & learning — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Bacopa Monnieri wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Verdict
Too few graded studies
1 of 1 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Bacopa Monnieri and Sage have evidence — compare verdict strength side-by-side.
300-450mg daily (standardized to 50% bacosides)
With fatty meal for absorption
Bacognize® or Synapsa® standardized extract
300–600 mg standardized extract daily
With breakfast, With dinner (split dosing)
Standardized extract (300–600 mg, 2.5% rosmarinic acid)
and 4 more not shown
8-12 weeks
8-12 weeks
First 2 weeks
First week
4–8 weeks
4–8 weeks
4–8 weeks
8–12 weeks
Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review
Nutrients (2025) · Systematic review
The evidence revealed the potential use of supplements as complementary ADHD treatments under clinical guidance.
Effectiveness of Bacopa Monnieri (Brahmi) in the management of schizophrenia: a systematic review
Nutritional neuroscience (2025) · Systematic review
Schizophrenia is a psychotic disorder affecting approximately 0.32% of the global population.
Bacopa monnieri: Preclinical and Clinical Evidence of Neuroactive Effects, Safety of Use and the Search for Improved Bioavailability
Nutrients (2025) · Review
Animal studies have shown promising results in reducing symptoms and protecting against neurodegeneration.
Systematic review of clinical trials assessing pharmacological properties of Salvia species on memory, cognitive impairment and Alzheimer's disease.
CNS Neuroscience & Therapeutics (2014) · Systematic review
Eight clinical studies were included: six on cognitive performance in healthy subjects and two on Alzheimer's disease.
Exploring the therapeutic impact of Salvia officinalis on lipid and oxidative stress markers in patients with polycystic ovary syndrome - a randomized placebo-controlled clinical trial.
BMC Complementary Medicine and Therapies (2025) · Rct · n=70
70 women with newly diagnosed PCOS were randomized to receive either 330 mg of S. officinalis extract or placebo daily for eight weeks.
Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease
J Clin Pharm Ther (2003) · Rct · n=42
42 patients aged 65-80 with mild to moderate Alzheimer's disease were randomized to a fixed dose of S. officinalis extract (60 drops/day) or placebo for 4 months.
The 300 mg point rests on four 12-week placebo-controlled trials of standardised extracts at 300 mg a day. Three found better verbal learning or delayed recall than placebo (PMID 11498727, 20590480 with 98 older adults, 18611150 with 54 adults over 65). The largest, 101 adults with memory complaints (PMID 41091332), found no difference in verbal learning, attention or working memory. The 160 mg point is one 2-month trial in 62 people with mild cognitive impairment (PMID 38538390): attention improved, and the overall cognitive score differed from placebo only at the final visit. No trial compared doses within one study, and none gave more than 300 mg a day for weeks, so no optimal dose or safety ceiling can be read from them. Two trials reported more gastrointestinal complaints on bacopa.
Based on multiple RCTs showing improvements in word recall, working memory, and attention. Effects varied by specific cognitive domain and population. Most studies used standardized extracts.
AI-estimated from published studies. Interpret as directional guidance.
Bacopa Monnieri has a higher evidence score (6/10 vs 6/10) and wins in 2 of 3 categories.
For improve memory & learning, Bacopa Monnieri has a higher relevance score (95 vs 78).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
Caffeine+L-theanine works; bacopa needs weeks; most "brain pills" are hype. The honest tier list.
Hot flashes, bone, sleep, muscle — the basics that hold up vs the phytoestrogen hype.
What’s safe while nursing, the truth about milk-supply herbs, and what to avoid (it passes into milk).
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.